Conference item icon

Conference item

Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Subtitle:
Conference abstract
Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Authors


Expand authors...
Publisher:
American Society of Hematology Publisher's website
Volume:
128
Issue:
22
Pages:
1065
Publication date:
2016-12-01
Acceptance date:
2016-12-01
EISSN:
1528-0020
ISSN:
0006-4971
Pubs id:
pubs:907205
URN:
uri:28e006fb-8f0c-4be0-af75-c98737185efb
UUID:
uuid:28e006fb-8f0c-4be0-af75-c98737185efb
Local pid:
pubs:907205

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP